Showing the single result

  • Cablivi caplacizumab
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Cablivi (caplacizumab) Online For Sale

    $4,043.55

    DISEASE INDICATIONS: Acquired thrombotic thrombocytopenic purpura (aTTP)

    MANUFACTURER: Ablynx NV

    USAGE: Intravenous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Health Canada

    Therapeutic Goods Administration (TGA)

    Cablivi (caplacizumab) is a medication for treating acquired thrombotic thrombocytopenic purpura in adult patients by reducing the formation of blood clots in small blood vessels.

    Select options This product has multiple variants. The options may be chosen on the product page